Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.
2.

The Safety of Appropriate Use of Over-the-Counter Proton Pump Inhibitors: An Evidence-Based Review and Delphi Consensus.

Johnson DA, Katz PO, Armstrong D, Cohen H, Delaney BC, Howden CW, Katelaris P, Tutuian RI, Castell DO.

Drugs. 2017 Apr;77(5):547-561. doi: 10.1007/s40265-017-0712-6. Review.

3.

Effects of omeprazole or pantoprazole on platelet function in non-ST-segment elevation acute coronary syndrome patients receiving clopidogrel.

Gu RX, Wang XZ, Li J, Deng J, Li XX, Wang J.

Mil Med Res. 2016 Dec 15;3:38. doi: 10.1186/s40779-016-0107-0. eCollection 2016.

4.

Effects of the short-term application of pantoprazole combined with aspirin and clopidogrel in the treatment of acute STEMI.

Wei P, Zhang YG, Ling L, Tao ZQ, Ji LY, Bai J, Zong B, Jiang CY, Zhang Q, Fu Q, Yang XJ.

Exp Ther Med. 2016 Nov;12(5):2861-2864. Epub 2016 Sep 9.

6.

Medical cannabis - the Canadian perspective.

Ko GD, Bober SL, Mindra S, Moreau JM.

J Pain Res. 2016 Sep 30;9:735-744. eCollection 2016. Review.

7.

Diclofenac- and Pantoprazole-Induced Rhabdomyolysis: A Potential Drug Interaction.

Ertekin YH, Yakar B, Ertekin H, Uludağ A, Tekin M.

Drug Saf Case Rep. 2015 Dec;2(1):10. Review.

8.

Omeprazole induces heme oxygenase-1 in fetal human pulmonary microvascular endothelial cells via hydrogen peroxide-independent Nrf2 signaling pathway.

Patel A, Zhang S, Shrestha AK, Maturu P, Moorthy B, Shivanna B.

Toxicol Appl Pharmacol. 2016 Nov 15;311:26-33. doi: 10.1016/j.taap.2016.10.002. Epub 2016 Oct 8.

PMID:
27725188
9.

Proton pump inhibitors decrease eotaxin-3/CCL26 expression in patients with chronic rhinosinusitis with nasal polyps: Possible role of the nongastric H,K-ATPase.

Min JY, Ocampo CJ, Stevens WW, Price CP, Thompson CF, Homma T, Huang JH, Norton JE, Suh LA, Pothoven KL, Conley DB, Welch KC, Shintani-Smith S, Peters AT, Grammer LC 3rd, Harris KE, Hulse KE, Kato A, Modyanov NN, Kern RC, Schleimer RP, Tan BK.

J Allergy Clin Immunol. 2017 Jan;139(1):130-141.e11. doi: 10.1016/j.jaci.2016.07.020. Epub 2016 Oct 4.

PMID:
27717558
10.

Association of Proton Pump Inhibitors With Reduced Risk of Warfarin-Related Serious Upper Gastrointestinal Bleeding.

Ray WA, Chung CP, Murray KT, Smalley WE, Daugherty JR, Dupont WD, Stein CM.

Gastroenterology. 2016 Dec;151(6):1105-1112.e10. doi: 10.1053/j.gastro.2016.08.054. Epub 2016 Sep 14.

PMID:
27639805
11.

Antioxidant Properties and Gastroprotective Effects of 2-(Ethylthio)Benzohydrazones on Ethanol-Induced Acute Gastric Mucosal Lesions in Rats.

Nazarbahjat N, Kadir FA, Ariffin A, Abdulla MA, Abdullah Z, Yehye WA.

PLoS One. 2016 Jun 7;11(6):e0156022. doi: 10.1371/journal.pone.0156022. eCollection 2016.

12.

Warfarin-induced raised international normalized ratio is further prolonged by pantoprazole.

Chandelia S, Dubey NK.

Indian J Crit Care Med. 2016 Feb;20(2):127-8. doi: 10.4103/0972-5229.175934. No abstract available.

13.

Omeprazole does not Potentiate Acute Oxygen Toxicity in Fetal Human Pulmonary Microvascular Endothelial Cells Exposed to Hyperoxia.

Patel A, Zhang S, Moorthy B, Shivanna B.

Pharm Anal Acta. 2015 Oct;6(10). pii: 424. Epub 2015 Oct 9.

14.

Trends in the coprescription of proton pump inhibitors with clopidogrel: an ecological analysis.

Juurlink DN, Gomes T, Paterson JM, Hellings C, Mamdani MM.

CMAJ Open. 2015 Nov 26;3(4):E428-31. doi: 10.9778/cmajo.20140078. eCollection 2015 Oct-Dec.

15.

The gastroprotective effects of hydroalcoholic extract of Monolluma quadrangula against ethanol-induced gastric mucosal injuries in Sprague Dawley rats.

Ibrahim IA, Abdulla MA, Hajrezaie M, Bader A, Shahzad N, Al-Ghamdi SS, Gushash AS, Hasanpourghadi M.

Drug Des Devel Ther. 2015 Dec 30;10:93-105. doi: 10.2147/DDDT.S91247. eCollection 2016.

16.

Changes in Practice Patterns of Clopidogrel in Combination with Proton Pump Inhibitors after an FDA Safety Communication.

Guérin A, Mody R, Carter V, Ayas C, Patel H, Lasch K, Wu E.

PLoS One. 2016 Jan 4;11(1):e0145504. doi: 10.1371/journal.pone.0145504. eCollection 2016.

17.

Efficacy of Clopidogrel and Clinical Outcome When Clopidogrel Is Coadministered With Atorvastatin and Lansoprazole: A Prospective, Randomized, Controlled Trial.

Zhang JR, Wang DQ, Du J, Qu GS, Du JL, Deng SB, Liu YJ, Cai JX, She Q.

Medicine (Baltimore). 2015 Dec;94(50):e2262. doi: 10.1097/MD.0000000000002262.

18.

Omeprazole induces NAD(P)H quinone oxidoreductase 1 via aryl hydrocarbon receptor-independent mechanisms: Role of the transcription factor nuclear factor erythroid 2-related factor 2.

Zhang S, Patel A, Moorthy B, Shivanna B.

Biochem Biophys Res Commun. 2015 Nov 13;467(2):282-7. doi: 10.1016/j.bbrc.2015.09.173. Epub 2015 Oct 9.

19.

Omeprazole Attenuates Pulmonary Aryl Hydrocarbon Receptor Activation and Potentiates Hyperoxia-Induced Developmental Lung Injury in Newborn Mice.

Shivanna B, Zhang S, Patel A, Jiang W, Wang L, Welty SE, Moorthy B.

Toxicol Sci. 2015 Nov;148(1):276-87. doi: 10.1093/toxsci/kfv183. Epub 2015 Aug 13.

20.

Incidence of cardiovascular events and gastrointestinal bleeding in patients receiving clopidogrel with and without proton pump inhibitors: an updated meta-analysis.

Cardoso RN, Benjo AM, DiNicolantonio JJ, Garcia DC, Macedo FY, El-Hayek G, Nadkarni GN, Gili S, Iannaccone M, Konstantinidis I, Reilly JP.

Open Heart. 2015 Jun 30;2(1):e000248. doi: 10.1136/openhrt-2015-000248. eCollection 2015.

Supplemental Content

Support Center